S'abonner

Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology - 13/12/18

Doi : 10.1016/j.jaad.2018.04.033 

Task Force/Committee Members

Claudia I. Vidal, MD, PhD a, , Eric A. Armbrect, PhD b, Aleodor A. Andea, MD c, Angela K. Bohlke, MD, PhD d, Nneka I. Comfere, MD e, Sarah R. Hughes, MD f, Jinah Kim, MD, PhD g, Jessica A. Kozel, MD h, Jason B. Lee, MD i, Konstantinos Linos, MD j, Brandon R. Litzner, MD k, l, Tricia A. Missall, MD, PhD a, Roberto A. Novoa, MD g, Uma Sundram, MD, PhD m, Brian L. Swick, MD n, M. Yadira Hurley, MD a : Chair,

Rating Panel

Murad Alam, MD, MSCI, MBA o, Zsolt Argenyi, MD p, Lyn M. Duncan, MD q, Dirk M. Elston, MD r, Patrick O. Emanuel, MBChB s, Tammie Ferringer, MD t, Maxwell A. Fung, MD u, Gregory A. Hosler, MD, PhD v, Alexander J. Lazar, MD, PhD w, Lori Lowe, MD c, Jose A. Plaza, MD x, Victor G. Prieto, MD, PhD w, June K. Robinson, MD y, Andras Schaffer, MD, PhD z, Antonio Subtil, MD, MBA aa, Wei-Lien Wang, MD bb
a Departments of Dermatology and Pathology, Saint Louis University School of Medicine, Saint Louis, Missouri 
b Center for Health Outcomes Research, Saint Louis University, Saint Louis, Missouri 
c Departments of Dermatology and Pathology, University of Michigan Medical Center, Ann Arbor, Michigan 
d Silver Falls Dermatology, Salem, Oregon 
e Department of Dermatology and Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 
f Department of Pathology, Gundersen Health System, La Crosse, Wisconsin 
g Departments of Dermatology and Pathology, Stanford University School of Medicine, Stanford, California 
h Midwest Pathology Associates, LLC, Overland Park, Kansas 
i Departments of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 
j Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center and Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire 
k Departments of Dermatology and Pathology, Via Christi Clinic, Ascension Medical Group, Wichita, Kansas 
l Department of Family Medicine, University of Kansas Medical Center, Wichita, Kansas 
m Department of Anatomic Pathology, Oakland University William Beaumont School of Medicine and Beaumont Health Systems, Royal Oak, Michigan 
n Departments of Dermatology and Pathology, University of Iowa, Iowa City, Iowa 
o Departments of Dermatology Otolaryngology, and Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 
p Department of Pathology, University of Washington, Seattle, Washington 
q Pathology Service and Dermatopathology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 
r Department of Dermatology, Dermatologic Surgery Medical University of South Carolina, Charleston, South Carolina 
s Department of Pathology and Molecular Medicine, University of Auckland, Auckland, New Zealand 
t Departments of Dermatology and Laboratory Medicine, Geisinger Medical Center, Danville, Pennsylvania 
u Departments of Dermatology and Pathology and Laboratory Medicine, University of California, Davis School of Medicine, Sacramento, California 
v ProPath and Departments of Dermatology and Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 
w Departments of Pathology, Dermatology, and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 
x Miraca Life Sciences, Irving, Texas 
y Department of Dermatology, Northwestern University, Chicago, Illinois 
z Bey Dermatology and Cosmetic Surgery, Spring Hill, Florida 
aa Department of Dermatology, Yale School of Medicine, New Haven, Connecticut 
bb Departments of Pathology and Translational Molecular Pathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 

Correspondence to: Claudia Irene Vidal, MD, PhD, St. Louis University, Department of Dermatology, 1755 S Grand Blvd, St. Louis, MO 63104.St. Louis UniversityDepartment of Dermatology1755 S Grand BlvdSt. LouisMO63104

Abstract

Background

Appropriate use criteria (AUC) provide physicians guidance in test selection, and can affect health care delivery, reimbursement policy, and physician decision-making.

Objectives

The American Society of Dermatopathology, with input from the American Academy of Dermatology and the College of American Pathologists, sought to develop AUC in dermatopathology.

Methods

The RAND/UCLA appropriateness methodology, which combines evidence-based medicine, clinical experience, and expert judgment, was used to develop AUC in dermatopathology.

Results

With the number of ratings predetermined at 3, AUC were developed for 211 clinical scenarios involving 12 ancillary studies. Consensus was reached for 188 (89%) clinical scenarios, with 93 (44%) considered “usually appropriate” and 52 (25%) “rarely appropriate” and 43 (20%) having “uncertain appropriateness.”

Limitations

The methodology requires a focus on appropriateness without comparison between tests and irrespective of cost.

Conclusions

The ultimate decision to order specific tests rests with the physician and is one where the expected benefit exceeds the negative consequences. This publication outlines the recommendations of appropriateness—the AUC for 12 tests used in dermatopathology. Importantly, these recommendations may change considering new evidence. Results deemed “uncertain appropriateness” and where consensus was not reached may benefit from further research.

Le texte complet de cet article est disponible en PDF.

Key words : ancillary studies, appropriate use criteria, dermatopathology, evidence-based medicine, expert rating

Abbreviations used : ASDP, AUC, UQ


Plan


 With permission from Vidal CI, Armbrect EA, Andea AA, et al. Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology, Journal of Cutaneous Pathology, Volume 45, pages 563-580, John Wiley & Sons A/S, 2018.
 Drs Vidal, Armbrect, Andea, Bohlke, Comfere, Hughes, Kim, Kozel, Lee, Linos, Litzner, Missall, Novoa, Sundram, Swick, and Hurley were members of the Appropriate Use Criteria (AUC) Task Force.
 Drs Alam, Argenyi, Duncan, Elston, Emanuel, Ferringer, Fung, Hosler, Lazar, Lowe, Plaza, Prieto, Robinson, Schaffer, Subtil, and Wang were members of the rating panel.
 Dr Hurley, as designated, was the Chair of the AUC Task Force / Committee and is the senior author.
 Drs Kim, Kozel, Litzner, and Sundram were AUC subgroup leaders.
 Drs Argenyi, Duncan, Ferringer, Fung, Holser, Lowe, Plaza, Prieto, Subtil, and Wang and Emanuel were American Society of Dermatopathology representatives.
 Dr Elston was the American Society of Dermatopathology President during the time of AUC development.
 Drs Alam and Robinson were the American Academy of Dermatology representative.
 Drs Lazar and Schaffer were College of American Pathologist representatives.
 Funding sources: None.
 Conflicts of interest: None disclosed.
 Disclaimer: The recommendations presented in this study were developed using the RAND Corporation (Santa Monica, CA) and University of California, Los Angeles, appropriateness method. Appropriateness ratings represent the best interpretation of the literature combined with expert judgment at the time of their development. The selection of a test ultimately lies with the physician and the assessment of multiple factors associated with the individual patient. The clinical scenarios used should not be considered inclusive of all situations in which a test or study should or can be performed. In the future, with the availability of additional information, changes to these recommendations may be required.


© 2018  American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 80 - N° 1

P. 189 - janvier 2019 Retour au numéro
Article précédent Article précédent
  • Clinical spectrum of cutaneous melanoma morphology
  • Nikolai Klebanov, Nicole S. Gunasekera, William M. Lin, Elena B. Hawryluk, David M. Miller, Bobby Y. Reddy, Mitalee P. Christman, Derek Beaulieu, Suvithan Rajadurai, Lyn M. Duncan, Arthur J. Sober, Hensin Tsao
| Article suivant Article suivant
  • Guidelines of care for the management of primary cutaneous melanoma
  • Work Group, Susan M. Swetter, Hensin Tsao, Christopher K. Bichakjian, Clara Curiel-Lewandrowski, David E. Elder, Jeffrey E. Gershenwald, Valerie Guild, Jane M. Grant-Kels, Allan C. Halpern, Timothy M. Johnson, Arthur J. Sober, John A. Thompson, Oliver J. Wisco, Samantha Wyatt, Shasa Hu, Toyin Lamina

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.